Lam Research
LRCX
$263.94
-4.87%
Lam Research is one of the world's largest semiconductor wafer fabrication equipment (WFE) manufacturers, specializing in deposition and etch processes — the layer-by-layer buildup and selective removal of material that defines modern chip fabrication — and sells primarily to memory (DRAM/NAND) and logic foundry customers including TSMC, Samsung, Intel, and Micron. The company holds the top market share in etch and a clear second position in deposition, giving it a defensible oligopoly position alongside Applied Materials and Tokyo Electron in a market where process know-how and installed-base service revenue create high barriers to entry. The current investor narrative centers on Lam as a leveraged beneficiary of the AI infrastructure build-out — a Motley Fool piece even floated the question of whether it could become the next $1 trillion company — with bulls pointing to the Terafab-style fab construction boom and record AI-chip demand, while bears flag the stock's extreme valuation, its outsized memory-cycle exposure, and a sharp late-2026 drawdown that has erased a meaningful portion of its earlier gains despite still-strong fundamental momentum.…
LRCX
Lam Research
$263.94
Related headlines
Investment Opinion: Should I buy LRCX Today?
The synthesized recommendation is Hold, with a bias toward accumulating on further weakness. The core thesis is that Lam's fundamental momentum (29.99% revenue growth, 51.75% gross margin) and overwhelmingly bullish analyst consensus (strong_buy, $375.81 average target implying 42% upside) are offset by extreme valuation multiples and a severe technical breakdown that has erased 40% from the stock's high. The analyst consensus rating of 1.457 and average target of $375.81 anchor the view that the selloff has overshot, but the timing of a recovery is uncertain.
Supporting evidence includes the forward PE of 22.43x, which is reasonable for a 30%-growth leader, and the PEG ratio of 1.83, suggesting growth is not excessively priced. Revenue has accelerated for three consecutive quarters, margins are expanding (gross margin up from 49.60% in Q2 to 51.75% in Q4), and TTM free cash flow of $4.891 billion funds dividends and buybacks. The implied upside to the analyst average target is 42%, and even the low target of $290 is 10% above the current price. However, the PS ratio of 22.20x and EV/EBITDA of 59.08x are far above peer norms, and the trailing PE of 70.97x is at the high end of its historical range.
The biggest risks that could invalidate the thesis are a memory-cycle downturn, a delay in AI-capex spending, and continued multiple compression. The rating would upgrade to Buy if the stock stabilizes above $300 and forward EPS estimates hold at $17.30, or if the PE compresses below 20x on sustained growth. It would downgrade to Sell if revenue growth decelerates below 15% or if forward EPS estimates are cut below $14. The valuation verdict is fairly valued on a forward basis but overvalued on trailing metrics, suggesting the stock is pricing in a successful execution of the growth story.
Sign up to view all
LRCX 12-Month Price Forecast
Lam Research presents a balanced risk/reward at current levels. The fundamental story remains strong with accelerating revenue and expanding margins, and the analyst consensus is overwhelmingly bullish with a $375.81 average target. However, the stock's extreme valuation on trailing metrics and recent 24% two-week collapse signal that the market is repricing the AI-capex thesis. The forward PE of 22.43x offers a reasonable entry point if earnings estimates hold, but the high beta and memory-cycle exposure warrant caution. I would upgrade to bullish if the stock stabilizes above $300 and forward EPS estimates are revised upward, and downgrade to bearish if revenue growth decelerates below 15% or memory capex cuts materialize.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Lam Research's 12-month outlook, with a consensus price target around $375.81 and implied upside of +42.4% versus the current price.
Average Target
$375.81
0 analysts
Implied Upside
+42.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$290 - $500
Analyst target range
Coverage is deep and overwhelmingly bullish: 31 analysts cover Lam with a consensus recommendation of "strong_buy" (mean rating 1.457 on a 1-5 scale where 1 is a strong buy), and the average target price of $375.81 implies roughly +42% upside from the current $263.94. Notably, even the lowest analyst target of $290.00 sits about 10% above the current price, meaning the entire Street believes the stock is undervalued after its recent collapse — a striking signal of conviction. The consensus is unambiguously bullish, and the recent institutional ratings flow (UBS Buy, Mizuho Outperform, Wells Fargo Overweight, Morgan Stanley Overweight, Jefferies Buy, Evercore Outperform, Stifel Buy, Needham Buy) shows analysts reiterating positive ratings through the summer rather than downgrading into the weakness.
The target range of $290 to $500 is wide — a $210 spread, or roughly 56% of the average target — which signals meaningful uncertainty about the magnitude of the AI-capex cycle even as directionally everyone is bullish. The high target of $500 assumes multiple expansion and sustained 30%+ growth as AI and Terafab-driven fab construction accelerates, while the low target of $290 essentially prices in a modest recovery to just above current levels, implying margin compression or a memory-cycle pause. The fact that the low target is still above the current price suggests the selloff has overshot fundamental expectations, but the wide spread and the stock's 1.85 beta mean investors should expect continued volatility; the consensus EPS estimate of $17.30 (range $14.09-$19.91) is the key variable, and any guidance cut would quickly invalidate the bullish target structure.
Drowning in data?
Find the real signal!
Bulls vs Bears: LRCX Investment Factors
The bull case rests on Lam's accelerating revenue growth (29.99% YoY), expanding margins (51.75% gross, 33.88% net), and a strongly bullish analyst consensus with a $375.81 average target implying 42% upside. However, the bear case is equally compelling: extreme valuation multiples (70.97x trailing PE, 22.20x PS), a severe momentum breakdown with the stock 40% below its high, and outsized memory-cycle exposure. Currently, the bear evidence has the stronger near-term weight given the 24% two-week collapse and 18.44-point underperformance versus the S&P 500 over three months. The single most important tension is whether the forward EPS estimate of $17.30 is achievable—if it is, the forward PE of 22.43x is attractive; if not, the trailing 70.97x multiple is unsustainable.
Bullish
- Accelerating revenue growth: Fiscal Q4 2026 revenue of $6.722 billion grew 29.99% year-over-year, with sequential acceleration from $5.341 billion in Q2 to $5.841 billion in Q3. This trajectory supports the AI-capex narrative and underpins the analyst consensus revenue estimate of $55.75 billion.
- Elite and expanding margins: Gross margin reached 51.75% in Q4 2026, up from 49.83% in Q3 and 49.60% in Q2, while operating margin climbed to 37.39% from 35.04% and 33.87%. Net margin of 33.88% and ROE of 58.26% reflect strong pricing power and operating leverage.
- Analyst consensus strongly bullish: 31 analysts rate the stock a 'strong_buy' with a mean rating of 1.457, and the average target price of $375.81 implies 42% upside from $263.94. Even the lowest target of $290 is 10% above the current price, signaling broad conviction.
- Attractive forward valuation: The forward PE of 22.43x is reasonable for a 30%-growth semiconductor-equipment leader, especially compared to the trailing PE of 70.97x. The PEG ratio of 1.83 suggests growth is not excessively priced relative to the multiple.
Bearish
- Extreme valuation multiples: The stock trades at 22.20x sales, 14.88x EV/Sales, 59.08x EV/EBITDA, and 41.35x book value—far above typical semiconductor-equipment peers. The trailing PE of 70.97x is near the top of its historical range of 9x-34x, leaving little room for error.
- Severe momentum breakdown: The stock is down 15.75% over three months and 4.87% in the latest session, sitting 40% below its 52-week high of $438.50. It has lagged the S&P 500 by 18.44 percentage points over three months, signaling a repricing of the AI-capex thesis.
- Memory-cycle exposure: Roughly 63% of revenue is systems-driven, and Lam is more exposed to memory chipmakers (DRAM/NAND) than peers. A pause in memory capex could disproportionately impact revenue, as evidenced by the wide analyst revenue range of $47.78 billion to $62.21 billion.
- High volatility and beta: Beta of 1.854 means the stock is 85% more volatile than the S&P 500, and the max drawdown of 41.76% confirms bear-market-caliber declines. A 4.87% single-day drop is consistent with this risk profile, requiring careful position sizing.
LRCX Technical Analysis
Lam Research is in a powerful but violently volatile longer-term uptrend that has recently rolled over into a corrective phase: the stock is up 85.39% over the past year and 42.62% year-to-date, yet the current price of $263.94 sits only about 42% of the way up its 52-week range of $135.50 to $438.50. That positioning — a huge annual gain but a price now closer to the low than the high — signals a momentum unwind rather than a clean trend, and the 41.76% max drawdown confirms the stock has already suffered a bear-market-caliber decline from its peak. The stock is trading roughly 40% below its 52-week high, meaning the prior uptrend's leadership has broken down and the burden of proof now sits with the bulls to re-establish a higher low.
Short-term momentum is decisively negative and diverging sharply from the still-positive 1-year trend: the stock is down 15.75% over three months and 1.96% over one month, but the most recent tape is far worse — a 4.87% single-day drop on the latest session and a slide from $347.49 on October 2 to $263.94 on October 16, a roughly 24% decline in two weeks. Relative strength confirms the underperformance, with LRCX lagging SPY by 18.44 percentage points over three months and 3.18 points over one month even as the S&P itself gained 2.69% and 1.22% respectively. This is a classic momentum breakdown where the 1-month and 3-month numbers understate the damage because the collapse is so recent; the divergence between the +85% annual gain and the -15.75% quarterly loss suggests the market is repricing the AI-capex thesis rather than merely taking profits.
Key technical levels are now clearly defined: support sits at the 52-week low of $135.50, with the $250-$260 zone (the July 2026 lows around $252) acting as the immediate battleground, while resistance is the 52-week high of $438.50 and, more realistically, the $347-$350 area that capped the early-October rally. A breakdown below $250 would open the door toward the $200s and signal that the correction is deepening into a full trend reversal, whereas reclaiming $300-$310 would be the first evidence of a durable bottom. With a beta of 1.854, Lam is roughly 85% more volatile than the S&P 500, meaning position sizing must account for swings nearly double the market's — a 4.87% daily drop is entirely consistent with this risk profile, and the 2.81 short ratio plus 11.3 million share volume indicate active, conviction-driven selling rather than passive drift.
Beta
1.85
1.85x market volatility
Max Drawdown
-41.8%
Largest decline past year
52-Week Range
$136-$439
Price range past year
Annual Return
+85.4%
Cumulative gain past year
| Period | LRCX Return | S&P 500 |
|---|---|---|
| 1m | -2.0% | +0.2% |
| 3m | -15.8% | +2.9% |
| 6m | -1.4% | +8.4% |
| 1y | +85.4% | +14.9% |
| ytd | +42.6% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LRCX Fundamental Analysis
Lam's revenue trajectory remains robustly growth-oriented even as the stock corrects: fiscal Q4 2026 (quarter ended June 28, 2026) revenue was $6.722 billion, up 29.99% year-over-year, and the multi-quarter progression shows steady acceleration — from $5.341 billion in Q2 2026 to $5.841 billion in Q3 to $6.722 billion in Q4, with each quarter's YoY growth building on the last (Q4 2025 revenue was $5.171 billion). The segment mix shows systems revenue of $4.250 billion versus customer support and other at $2.472 billion, meaning roughly 63% of revenue is equipment-driven and therefore highly cyclical, while the 37% service/support base provides a recurring cushion. This growth profile — nearly 30% YoY with sequential acceleration — is exactly what the AI-capex narrative requires, and it explains why analysts model average forward revenue of $55.75 billion (range $47.78 billion to $62.21 billion) despite the recent price weakness.
Profitability is exceptional and expanding: Q4 2026 net income was $2.277 billion on a 33.88% net margin, with gross margin at 51.75% (up from 49.83% in Q3 and 49.60% in Q2) and operating margin at 37.39% — a clear upward march from 35.04% in Q3 and 33.87% in Q2. The company is solidly profitable with EPS of $1.82 in the latest quarter (diluted $1.81), and the margin expansion is being driven by operating leverage as revenue scales faster than the cost base (R&D of $642.9 million and SG&A of $322.3 million grew far more slowly than the 30% top-line). A 51.75% gross margin and 33.88% net margin are elite even by semiconductor-equipment standards, reflecting pricing power in etch/deposition and a favorable mix shift toward high-value systems.
Balance-sheet and cash-flow health are strong but show some working-capital strain: debt-to-equity is a modest 0.33, the current ratio is a healthy 2.63, and ROE is an outstanding 58.26% with ROA of 22.84%, while TTM free cash flow is $4.891 billion. However, quarterly FCF has been uneven — $822 million in Q4 2026 versus $1.665 billion in Q2 and $1.594 billion in Q1 — because Q4 operating cash flow of $1.457 billion was dragged down by a $1.039 billion working-capital outflow and $634.8 million of capex, even as the company returned cash via $325.3 million in dividends and $246.6 million in buybacks. The company clearly funds growth internally (cash balance of $5.598 billion) and carries little leverage risk, but the FCF yield is thin at roughly 0.95% on a $515.7 billion market cap, meaning investors are paying heavily for that cash generation.
Quarterly Revenue
$6.7B
2026-06
Revenue YoY Growth
+30.0%
YoY Comparison
Gross Margin
51.7%
Latest Quarter
Free Cash Flow
$4.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LRCX Overvalued?
Because Lam is solidly profitable (net income of $2.277 billion in the latest quarter), the PE ratio is the appropriate primary metric: the trailing PE is 70.97x while the forward PE is just 22.43x, an enormous gap that implies the market expects earnings to roughly triple — consistent with the analyst consensus EPS estimate of $17.30 versus the trailing figure. That forward multiple of 22.4x is actually reasonable for a 30%-growth semiconductor-equipment leader, but the trailing 71x reflects how much of the current price is a bet on future earnings materializing; the PEG ratio of 1.83 suggests the growth is not cheap relative to the multiple. The market is clearly pricing in the forward earnings recovery, and the entire valuation debate hinges on whether that $17.30 EPS estimate is achievable.
On peer comparison, Lam screens expensive on most multiples: its PS ratio of 22.20x, EV/Sales of 14.88x, EV/EBITDA of 59.08x, and price-to-book of 41.35x are all far above what is typical for the semiconductor-equipment group, where mid-single-digit to low-double-digit EV/Sales is more common. The 22.4x forward PE is closer to peer norms, but the 59x EV/EBITDA and 41x P/B represent a substantial premium that can only be justified by Lam's superior margins (51.75% gross, 33.88% net) and its top etch share — which it does possess, but the premium leaves little room for error. Relative to its own history, the stock is near the top of its valuation band: the historical PE ratio ranged from roughly 9x-34x over the past several years (e.g., 18.0x in Q4 2025, 26.4x in Q1 2026, 34.2x in Q3 2026) before spiking to the current 70.97x, and P/B has climbed from 12.6x a year ago to 41.4x today. This is a valuation at the extreme high end of its own range, which typically signals either optimistic expectations being priced in or a temporary earnings trough inflating the trailing multiple — here it is likely both, and the recent 24% price decline is the market beginning to compress that premium.
PE
71.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
59.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on Lam's dependence on continued growth to justify its valuation. The trailing PE of 70.97x versus forward PE of 22.43x implies the market expects earnings to nearly triple to $17.30 per share, and any shortfall would compress the multiple sharply. Revenue concentration is another concern: 63% of revenue ($4.250 billion of $6.722 billion) comes from cyclical systems sales, while the 37% service/support base provides only a partial cushion. Additionally, quarterly free cash flow has been uneven—$822 million in Q4 2026 versus $1.665 billion in Q2—due to a $1.039 billion working-capital outflow, and the FCF yield is thin at roughly 0.95% on a $515.7 billion market cap.
Market and competitive risks are elevated by the stock's premium valuation and high beta. At 22.20x sales and 59.08x EV/EBITDA, Lam trades at a substantial premium to semiconductor-equipment peers, leaving it vulnerable to multiple compression if growth decelerates or sentiment shifts. The beta of 1.854 means the stock is 85% more volatile than the S&P 500, amplifying market downturns. Recent news highlights emerging threats: Samsung's strong earnings triggered a 'sell the news' event that dragged down semiconductor stocks, and a Motley Fool article warned of potential overvaluation in AI-related sectors. Competitive pressure from Applied Materials and Tokyo Electron, plus the risk of a memory-cycle pause, could further erode Lam's pricing power.
The worst-case scenario involves a simultaneous memory-cycle downturn and AI-capex disappointment, leading to earnings estimates being cut and the forward PE compressing toward the historical low end. In this scenario, the stock could retest its 52-week low of $135.50, representing a 49% decline from the current $263.94. Even a more moderate bear case, aligning with the analyst low target of $290, is actually above the current price, but the 52-week low provides a realistic downside anchor given the 41.76% max drawdown already experienced. Investors could lose 35-49% from current levels in an adverse scenario, underscoring the importance of position sizing given the 1.854 beta.
FAQ
The most severe risk is a memory-cycle downturn, as 63% of revenue is systems-driven and Lam is more exposed to memory chipmakers than peers. Second is valuation compression: the trailing PE of 70.97x and PS of 22.20x leave little room for error, and any earnings miss could trigger a sharp selloff. Third is competitive pressure from Applied Materials and Tokyo Electron, which could erode Lam's etch market share. Fourth is macro sensitivity, with a beta of 1.854 meaning the stock is 85% more volatile than the S&P 500, amplifying market downturns. These risks are ranked by severity, with memory-cycle exposure being the most immediate threat.
The 12-month forecast has three scenarios: a bull case (30% probability) targeting $438-$500 if AI-capex accelerates and EPS estimates are met; a base case (50% probability) targeting $350-$400, aligning with the analyst average target of $375.81; and a bear case (20% probability) targeting $135-$290 if a memory downturn occurs. The base case is most likely, assuming revenue growth of 25-30% and forward EPS of $17.30 is achieved. The key assumption is that memory capex remains stable and AI infrastructure spending continues to grow, supporting Lam's revenue trajectory.
LRCX is fairly valued on a forward basis but overvalued on trailing metrics. The forward PE of 22.43x is reasonable for a 30%-growth semiconductor-equipment leader, and the PEG ratio of 1.83 suggests growth is not excessively priced. However, the trailing PE of 70.97x, PS ratio of 22.20x, and EV/EBITDA of 59.08x are far above peer norms and near the high end of the stock's historical range. The market is pricing in a successful execution of the $17.30 EPS estimate, which implies earnings nearly tripling. If achieved, the stock is undervalued; if not, the premium multiples could compress sharply.
From a risk/reward perspective, LRCX offers a compelling opportunity for long-term investors willing to tolerate volatility. The stock trades at $263.94, 42% below the analyst average target of $375.81, and even the lowest target of $290 is 10% above the current price. The forward PE of 22.43x is attractive for a company growing revenue at 30% with 51.75% gross margins. However, the biggest downside risk is a memory-cycle downturn that could push the stock toward its 52-week low of $135.50, a 49% decline. Therefore, it is a good buy for investors with a 2-3 year horizon who can withstand a 1.854 beta and potential 40% drawdowns, but those with shorter horizons may want to wait for technical stabilization above $300.
LRCX is best suited for long-term investment with a minimum holding period of 2-3 years. The company is in a growth stage, benefiting from the multi-year AI infrastructure build-out, and its dividend yield of 0.25% is negligible, indicating a focus on growth over income. The beta of 1.854 and 41.76% max drawdown make it unsuitable for short-term trading unless using strict risk management. Earnings visibility is moderate, with analyst estimates ranging widely ($14.09-$19.91 EPS), suggesting that long-term investors should be prepared for volatility but can capitalize on the secular growth trend in semiconductor equipment.
